LMO2
Gene Information
- Official Symbol: LMO2
- Official Name: LIM domain only 2
- Aliases and Previous Symbols: N/A
- Entrez ID: 4005
- UniProt: P25791
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Acts with TAL1/SCL to regulate red blood cell development. Also acts with LDB1 to maintain erythroid precursors in an immature state.
Pfam Domains GO Terms
Pfam Domains
| LIM |
GO Terms
| cellular response to thyroid hormone stimulus |
| cofactor binding |
| mRNA transcription by RNA polymerase II |
| mRNA transcription |
| bHLH transcription factor binding |
| response to thyroid hormone |
| E-box binding |
| RNA polymerase II activating transcription factor binding |
| regulation of hematopoietic stem cell differentiation |
| regulation of hematopoietic progenitor cell differentiation |
| regulation of stem cell differentiation |
| transcription factor complex |
| RNA polymerase II regulatory region sequence-specific DNA binding |
| DNA-binding transcription activator activity, RNA polymerase II-specific |
| regulation of hemopoiesis |
| transcription by RNA polymerase II |
| cellular response to hormone stimulus |
| transcription, DNA-templated |
| nucleic acid-templated transcription |
| RNA biosynthetic process |
| mRNA metabolic process |
| response to hormone |
| nucleobase-containing compound biosynthetic process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| positive regulation of transcription by RNA polymerase II |
| cellular response to endogenous stimulus |
| organic cyclic compound biosynthetic process |
| response to endogenous stimulus |
| positive regulation of transcription, DNA-templated |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| cellular nitrogen compound biosynthetic process |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| regulation of immune system process |
| RNA metabolic process |
| cellular macromolecule biosynthetic process |
| positive regulation of RNA metabolic process |
| macromolecule biosynthetic process |
| regulation of cell differentiation |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| gene expression |
| positive regulation of biosynthetic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| LDB1 | 0.628 |
| ERG | 0.614 |
| SSBP2 | 0.587 |
| SOX7 | 0.549 |
| CBFB | 0.524 |
| DOHH | 0.523 |
| LYL1 | 0.5 |
| NSD1 | 0.494 |
| FLI1 | 0.493 |
| CCDC101 | 0.492 |
| ID3 | 0.491 |
| ZNF319 | 0.476 |
| BAP1 | 0.468 |
| RPTOR | 0.46 |
| AGO2 | 0.456 |
| RNMT | 0.447 |
| TRMT10A | 0.436 |
| LSM11 | 0.435 |
| PIAS4 | 0.432 |
| THG1L | 0.432 |
| ZFX | 0.428 |
| XPO6 | 0.424 |
| DPAGT1 | 0.418 |
| MED16 | 0.416 |
| ASB3 | 0.415 |
| ATXN10 | 0.414 |
| SCAF8 | 0.409 |
| ZNF410 | 0.405 |
| SRP14 | 0.401 |
| PELO | 0.401 |
| TTC4 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 5/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 5/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 14617
- Expression level (log2 read counts): 3.43
Expression Distribution
LMO2 Expression in NALM6 Cells: 3.43